Migraine: preventive treatment (Q34852689)

4 August 2017

1 reference

title

Migraine: preventive treatment. (English)

1 reference

4 August 2017

1 reference

2

P J Goadsby

1 reference

4 August 2017

S D Silberstein

1

1 reference

PubMed ID

12230591

4 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

22

1 reference

4 August 2017

7

1 reference

4 August 2017

491-512

1 reference

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

4 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

21 January 2018

Migraine and pregnancy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

The prophylactic value of propranolol in angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

The treatment of migraine with propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Propranolol in the management of recurrent migraine: a meta-analytic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Classic migraine: effective prophylaxis with metoprolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Acetylsalicylic acid vs. metoprolol in migraine prophylaxis--a double-blind cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Short-term clinical trial of phopranolol in racemic form (Inderal), D-propranolol and placebo in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Atenolol in migraine prophylaxis a double-blind cross-over multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

A Double Blind Trial of Acebutolol For Migraine Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Clinical trial of a beta-receptor blocking agent (LB 46) in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Propranolol in the Treatment of Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Migraine and beta-blockade: modulation of sympathetic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Beta-adrenergic blocker withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Long-acting propranolol in the prophylaxis of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Propranolol plasma levels and relief of migraine. Relationship between plasma propranolol and 4-hydroxypropranolol concentrations and clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Fluoxetine prophylaxis of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Amitriptyline in Migraine Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Amitriptyline in migraine prophylaxis: Changes in pattern of attacks during a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

A trial of opipramol in the treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Double-blind trial of fluoxetine: chronic daily headache and migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Migraine prophylaxis. A comparison of propranolol and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

A randomized general practice group-comparative study of femoxetine and placebo in the prophylaxis of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Desipramine relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Pain relief by antidepressants: possible modes of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Antidepressants and brain neurochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Antidepressants: A Clinical Update for Medical Practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Calcium-antagonist drugs. Receptor interactions that clarify therapeutic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Calcium channels in neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

The effects of flunarizine in experimental models related to the pathogenesis of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

A Placebo-Controlled, Double-Blind, Cross-Over Trial of Flunarizine in Common Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Flunarizine in migraine prophylaxis: an Indian trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Nimodipine in migraine: clinical efficacy and endocrinological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Comparison of the efficacy between flunarizine and nifedipine in the prophylaxis of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Nifedipine versus propranolol for the initial prophylaxis of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Diltiazem prophylaxis in refractory migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Do Anticonvulsants Reduce the Efficacy of Oral Contraceptives?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Divalproex sodium in migraine prophylaxis: a dose-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Migraine prophylaxis with divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Clonazepam (rivotril) in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Cerebrospinal fluid gamma aminobutyric acid levels in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Neuroexcitatory plasma amino acids are elevated in migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

An update on sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Mechanism of anticonvulsant action of valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

A rational guide to routine blood monitoring in patients receiving antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Valproic acid hepatic fatalities: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Divalproex sodium in headache: literature review and clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Divalproex in the long-term treatment of chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Serotonin syndrome complicating migraine pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Efficacy of gabapentin in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Is migraine prophylactic activity caused by 5-HT2B or 5-HT2C receptor blockade?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Effects of a selective 5-HT2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphe nucleus and 5-HT release and metabolism in the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Fibrotic Disorders Associated with Methysergide Therapy for Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

A comparison between BC 105 and methysergide in the prophylaxis of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Controlled trial of demigran in the prophylaxis of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Methysergide in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Double-blind crossover comparison of bc-105, methysergide and placebo in the prophylaxis of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

The ingestion of serotonin precursors (L-5-hydroxytryptophan and L-tryptophan) improves migraine headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

CLINICAL TRIAL OF METHYSERGIDE AND OTHER PREPARATIONS IN THE MANAGEMENT OF MIGRAINE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Silent Retroperitoneal Fibrosis Associated With Methysergide Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Cardiac murmurs and endocardial fibrosis associated with methysergide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Suppression of Human Growth Hormone Secretion by Melatonin and Cyproheptadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

A comparative study of naproxen sodium, pizotyline and placebo in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Pizotifen (BC 105) in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Sanomigran for Migraine Prophylaxis; Controlled Multicenter Trial in General Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Placebo, 1-Isopropylnoradrenochrome-5-Monosemicarbazono and Pizotifen in Migraine Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Herbal medicines in migraine prevention Randomized double-blind placebo-controlled crossover trial of a feverfew preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

31P-magnetic resonance spectroscopy in migraine without aura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Elevation of cerebral lactate detected by localized 1H-magnetic resonance spectroscopy in migraine during the interictal period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Low-dose aspirin for migraine prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Treatment review: non-steroid anti-inflammatory drugs in the treatment and long-term prevention of migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

"Hemicrania continua": a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Benign Intracranial Hypertension Associated With Hypervitaminosis A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Preventive treatment of migraine: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00386.X

10.1046/J.1468-2982.2002.00386.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12230591